Volume 96, Issue 15, 4 August 2004
MEMO TO THE MEDIA
Press Release: Adjuvant Chemotherapy for Colon Cancer Offers No Survival Benefit after 10 Years
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Page 1115, https://doi.org/10.1093/jnci/96.15.1115-a
Press Release: Activated Signaling Pathway May Predict Lung Cancer Patients' Response to Gefitinib
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Page 1115, https://doi.org/10.1093/jnci/96.15.1115-b
In This Issue
In THIS ISSUE
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Page 1115, https://doi.org/10.1093/jnci/96.15.1115
Editorial
Adjuvant Therapy for Colon Cancer: A Historical Perspective
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1116–1117, https://doi.org/10.1093/jnci/djh247
Predicting Sensitivity of Non–Small-Cell Lung Cancer to Gefitinib: Is There a Role for P-Akt?
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1117–1119, https://doi.org/10.1093/jnci/djh244
News
Environmental Protection: Studies Highlight Importance of Tumor Microenvironment
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1120–1121, https://doi.org/10.1093/jnci/96.15.1120
Cell of Origin: Mouse Model Offers Insights Into Process of Malignancy
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1122–1123, https://doi.org/10.1093/jnci/96.15.1122
Results of Cancer Care Quality Study Lead to Cautious Optimism, Caveats
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1124–1125, https://doi.org/10.1093/jnci/96.15.1124
Stat Bite: Health Insurance Coverage in the United States by Age Group, 2003
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Page 1125, https://doi.org/10.1093/jnci/96.15.1125
Project Creates Repository for Microarray Datasets
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Page 1126, https://doi.org/10.1093/jnci/96.15.1126
Awards, Appointments, Announcements
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Page 1127, https://doi.org/10.1093/jnci/96.15.1127
In Brief
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Page 1127, https://doi.org/10.1093/jnci/96.15.1127-a
Article
Randomized Trial of Adjuvant Therapy in Colon Carcinoma: 10-Year Results of NSABP Protocol C-01
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1128–1132, https://doi.org/10.1093/jnci/djh220
Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non–Small-Cell Lung Cancer
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1133–1141, https://doi.org/10.1093/jnci/djh217
HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1141–1151, https://doi.org/10.1093/jnci/djh198
Serum High-Density Lipoprotein Cholesterol, Metabolic Profile, and Breast Cancer Risk
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1152–1160, https://doi.org/10.1093/jnci/djh216
Associations Among β-TrCP, an E3 Ubiquitin Ligase Receptor, β-Catenin, and NF-κB in Colorectal Cancer
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1161–1170, https://doi.org/10.1093/jnci/djh219
Immune Cell–Mediated Antitumor Activities of GD 2 -Targeted Liposomal c-myb Antisense Oligonucleotides Containing CpG Motifs
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1171–1180, https://doi.org/10.1093/jnci/djh221
Correspondence
Re: Human Papillomavirus in Oral Exfoliated Cells and Risk of Head and Neck Cancer
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1181–1182, https://doi.org/10.1093/jnci/djh232
RESPONSE: Re: Human Papillomavirus in Oral Exfoliated Cells and Risk of Head and Neck Cancer
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1182–1183, https://doi.org/10.1093/jnci/djh233
Re: A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Page 1183, https://doi.org/10.1093/jnci/djh234
RESPONSE: Re: A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1183–1184, https://doi.org/10.1093/jnci/djh235
Re: BRCA1 and BRCA2 Founder Mutations and the Risk of Colorectal Cancer
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1184–1185, https://doi.org/10.1093/jnci/djh236
RESPONSE: Re: BRCA1 and BRCA2 Founder Mutations and the Risk of Colorectal Cancer
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1185–1186, https://doi.org/10.1093/jnci/djh237
Re: Decreasing Women’s Anxieties After Abnormal Mammograms: A Controlled Trial
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Pages 1186–1187, https://doi.org/10.1093/jnci/djh238
RESPONSE: Re: Decreasing Women’s Anxieties After Abnormal Mammograms: A Controlled Trial
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Page 1187, https://doi.org/10.1093/jnci/djh239
ONLINE COMMENTARY
Biannual Report of the Cochrane Haematological Malignancies Group
JNCI: Journal of the National Cancer Institute, Volume 96, Issue 15, 4 August 2004, Page E2, https://doi.org/10.1093/jnci/djh242
